References
- Noskin G, Peterson L, Warren J. Enterococcus faecium and Enterococcus faecalis bacteraemia: acquisition and outcome. Clin Infect Dis 1995; 20: 296–301
- Patterson JE, Sweeney AH, Simms M, Carley N, Mangi R, Sabetta J, et al. An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility and outcome. Medicine 1995; 74: 191–200
- Lodise TP, McKinnon PS, Tam VH, Rybak MJ. Clinical outcomes for patients with bacteraemia caused by vancomycin-resistant Enterococcus in a level 1 trauma centre. Clin Infect Dis 2002; 34: 922–9
- Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309–17
- Salgado CD, Farr BM. Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol 2003; 24: 690–8
- DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005; 41: 327–33
- Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, Golan Y, Noy A, Schwartz D, et al. Reappraisal of community-acquired bacteraemia: a proposal of a new classification for the spectrum of acquisition of bacteraemia. Clin Infect Dis 2002; 34: 1431–9
- Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, et al. Enterobacter bacteraemia: clinical features and emergence of antibiotic resistance during therapy. Annals of Internal Medicine 1991; 115: 585–90
- Li IS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633–8
- Gray J, Marsh PJ, Stewart D, Pedler SJ. Enterococcal bacteraemia: a prospective study of 125 episodes. J Hosp Infect 1994; 27: 179–86
- Peng MY, Young TG, Yang CH, Chou MY. Enterococcal bacteraemia in a medical centre. Zhonghua Yi Xue Za Zhi (Taipei) 1994; 54: 306–11
- Mohanty S, Kapil A, Das BK. Enterococcal bacteraemia in a tertiary care hospital of North India. J Indian Assoc 2005; 103: 31–7
- Fernandez Fernandez FJ, de la Fuente Aguado J, Rubianes Gonzalez M, Perez Fernandez S, Alvarez Fernandez M, Nodar Germinas A, et al. Enterococcus faecalis bacteraemia. Rev Clin Esp 2004; 204: 244–50
- Stroud L, Edwards J, Danzig L, Culver D, Gaynes R. Risk factors for mortality associated with enterococcal bloodstream infections. Infect Control Hosp Epidemiol 1996; 17: 576–80
- Huycke MM, Spiegel CA, Gilmore MS. Bacteraemia caused by haemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 1991; 35: 1626–34
- Caballer-Granado FJ, Cineros JM, Luque R, Torres-Tortosa M, Gamboa F, Diez F, et al. Comparative study of bacteraemias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el studio de las enfermedades infecciosas. J Clin Microbiol 1998; 36: 520–5
- Watanakunakorn C, Patel R. Comparison of patients with enterococcal bacteraemia due to strains with and without high-level resistance to gentamicin. Clin Infect Dis 1993; 17: 74–8
- Antalek MD, Mylotte JM, Lesse AJ, Sellik JA, Jr. Clinical and molecular epidemiology of Enterococcus faecalis bacteraemia, with special reference to strains with high-level resistance to gentamicin. Clin Infect Dis 1995; 20: 103–9
- Gleason TG, Crabtree TD, Pelletier SJ, Raymond DP, Karchmer TB, Pruett TL, et al. Prediction of poorer prognosis by infection with antibiotic-resistant Gram-positive cocci than by infection with antibiotic sensitive strains. Arch Surg 1999; 134: 1033–40
- Moellering RC. Enterococcus species, Streptococcus bovis, and Leuconostoc species. In: Mandell GL, Bennet JE, Dolin R, eds. Principles and practice of infectious diseases. 5th edn. Vol 2. Philadelphia: Churchill Livingstone; 2000. p. 2147–56.